Literature DB >> 6284529

Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.

R M Cohen, I C Campbell, I Yamaguchi, D Pickar, I J Kopin, D L Murphy.   

Abstract

Chronic (21 days) treatment with the selective monoamine oxidase (MAO)-A inhibitor clorgyline, but not with the MAO-B inhibitor deprenyl in pithed rats leads to increased blood pressure responses to sympathetic stimulation and intravenous tyramine, and to elevated unstimulated heart rates. No significant changes are observed in plasma catecholamine responses to sympathetic stimulation, nor in beta-adrenoreceptor numbers in heart ventricles. These findings suggest that the hypotensive effects of MAO inhibitors result from central nervous system rather than peripheral nervous system alterations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284529     DOI: 10.1016/0014-2999(82)90193-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  The effect of clorgyline on noradrenergic function.

Authors:  R J Ross; M Scheinin; P Lesieur; M V Rudorfer; R L Hauger; L J Siever; M Linnoila; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor.

Authors:  B Hazelhoff; J B De Vries; D Dijkstra; W de Jong; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

3.  Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat.

Authors:  J P Finberg; I J Kopin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.